PDM
GILD icon

Penn Davis McFarland’s Gilead Sciences GILD Stock Holding History

Penn Davis McFarland’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-267,243
Closed -$16.5M – 44
2022
Q2 		$16.5M Sell
267,243
-25,787
-9% -$1.6M 3.11% 14
2022
Q1 		$17.4M Sell
293,030
-638
-0.2% -$40.8K 2.8% 17
2021
Q4 		$21.3M Buy
293,668
+14,759
+5% +$1.02M 3.62% 11
2021
Q3 		$19.5M Buy
278,909
+1,360
+0.5% +$95.5K 3.56% 11
2021
Q2 		$19.1M Buy
277,549
+7,697
+3% +$514K 3.34% 13
2021
Q1 		$17.4M Buy
269,852
+1,770
+0.7% +$114K 3.34% 13
2020
Q4 		$15.6M Buy
268,082
+17,672
+7% +$1.07M 3.35% 14
2020
Q3 		$15.8M Buy
250,410
+2,058
+0.8% +$143K 4.12% 9
2020
Q2 		$19.1M Sell
248,352
-694
-0.3% -$53.2K 5.19% 6
2020
Q1 		$18.6M Buy
249,046
+179,572
+258% +$12.4M 6.47% 4
2019
Q4 		$4.51M Sell
69,474
-116,417
-63% -$7.58M 1.34% 19
2019
Q3 		$11.8M Buy
185,891
+308
+0.2% +$20.1K 3.69% 11
2019
Q2 		$12.5M Buy
185,583
+215
+0.1% +$14.1K 4.24% 10
2019
Q1 		$12.1M Buy
185,368
+6,587
+4% +$438K 4.17% 11
2018
Q4 		$11.2M Sell
178,781
-956
-0.5% -$66.8K 4.34% 9
2018
Q3 		$13.9M Buy
179,737
+887
+0.5% +$67K 4% 10
2018
Q2 		$12.7M Buy
178,850
+10,969
+7% +$775K 3.9% 11
2018
Q1 		$12.7M Buy
167,881
+326
+0.2% +$25.9K 3.87% 10
2017
Q4 		$12M Sell
167,555
-3,399
-2% -$258K 3.52% 11
2017
Q3 		$13.9M Sell
170,954
-8,652
-5% -$662K 4.29% 9
2017
Q2 		$12.7M Sell
179,606
-16,213
-8% -$1.08M 3.77% 8
2017
Q1 		$13.3M Buy
195,819
+15,193
+8% +$1.07M 3.88% 9
2016
Q4 		$12.9M Sell
180,626
-87,498
-33% -$6.5M 3.55% 12
2016
Q3 		$21.2M Buy
268,124
+89,423
+50% +$7.26M 5.43% 6
2016
Q2 		$14.9M Buy
178,701
+26,696
+18% +$2.37M 3.96% 11
2016
Q1 		$14M Buy
+152,005
New +$13.7M 3.66% 14

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Penn Davis McFarland's GILD Position: Q3 2022 in Review

Penn Davis McFarland sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 267,243 shares — an estimated $16.5M sold.

Penn Davis McFarland first reported a position in GILD in Q1 2016 and held it in 26 quarters. The position peaked at $21.3M in Q4 2021. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Penn Davis McFarland reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • Penn Davis McFarland sold 267,243 Gilead Sciences shares in Q3 2022, an estimated $16.5M.
  • Penn Davis McFarland first reported a position in Gilead Sciences in Q1 2016 and held it in 26 quarters.
  • Penn Davis McFarland's Gilead Sciences position peaked at $21.3M in Q4 2021.
  • 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Penn Davis McFarland's 13F filing for Q3 2022, filed 21 Oct 2022.